Renata Limited
 | |
| Type | Limited Company |
|---|---|
| DSE: RENATA | |
| Industry | Pharmaceutical |
| Founded | 1993 |
| Headquarters | , Bangladesh |
Area served | South Asia, South East Asia, Africa, Europe and Latin America |
| Key people | Syed S Kaiser Kabir (CEO) |
| Products | Maxpro, Rolac, Fenadin, Rolip, Furoclav and more |
Number of employees | 3485 |
| Website | renata-ltd |
Renata PLC (formerly Pfizer Laboratories (Bangladesh) Limited), also known as Renata Limited, is one of the top ten pharmaceutical manufacturers in Bangladesh in terms of revenue.[1] Renata is engaged in the manufacture and marketing of human pharmaceutical and animal health products.[2] The company also manufactures animal therapeutics and nutrition products. As of 2024, Renata employs about 11,000 people in its head office in Mirpur, Dhaka[3] and its 14 production facilities in Mirpur, Dhaka, Rajendrapur, Gazipur and Bhaluka, Mymensingh.[4]
Financial data
[edit]Renata is a publicly traded company on the Dhaka Stock Exchange (ticker: RENATA).[5]
Production facilities
[edit]Recently, Renata Limited has received the UK MHRA approval for its Potent Product Facility.[6] This facility is exporting prednisolone to the UK.[7]
The company also operates four other manufacturing units – the original Pfizer facility for general products, a UNICEF-approved SFF (Sachet Filling Facility).[8]
Partnerships
[edit]Recently, GAIN (The Global Alliance for Improved Nutrition) provided US$2.9 million to Renata Limited and BRAC, one of the biggest NGOs in the developing world, to build and operate an innovative business model to produce and deliver multi-nutrient powders to vulnerable infants in Bangladesh.[9]
Controversy
[edit]Renata was initially fined on 21 January 2016 by the Department of Environment for damaging the environment, though it was not finally proven. It was claimed by a group of company that Renata has also illegally occupied land owned by the forest department while they failed to provide any proof.[10] And also an unproven claim that, Syed S. Kaiser Kabir, the CEO, of the company had illegally grabbed government land to build a house near Dhaka-Mymensingh highway.[11]
References
[edit]- ↑ Haroon, Jasim Uddin (15 February 2010). "Square tops list of 10, Incepta second". The Financial Express. Dhaka. Archived from the original on 1 October 2011.
- ↑ "Renata Limited". Datamonitor. Archived from the original on 2011-07-28.
- ↑ "Renata Ltd". Wall Street Journal. Retrieved 9 September 2024.
- ↑ "Renata starts directly exporting medicines to US". The Daily Star. 4 April 2024.
- ↑ "Renata Ltd (RENATA:Dhaka)". Bloomberg Businessweek. Archived from the original on 5 October 2012.
- ↑ Chowdhury, Raihan M. (10 November 2007). "Pharmaceutical sector development necessitates vertical integration". The Financial Express. Dhaka.
- ↑ Khan, Jasim Uddin (4 June 2008). "Renata set to export medicine to Europe". The Daily Star.
- ↑ "Participants". Global Alliance for Improved Nutrition. Archived from the original on 2009-05-31.
- ↑ "GAIN's effectiveness in reducing malnutrition confirmed in its new Annual Report". Global Alliance for Improved Nutrition. Archived from the original on 2010-08-21.
- ↑ "অপকর্মে বেপরোয়া রেনাটা" অপকর্মে বেপরোয়া রেনাটা. Kaler Kantho (in Bengali). Retrieved 2018-01-10.
- ↑ রিমন, সাঈদুর; জিন্নাহ, শেখ. "অপকর্মে বেপরোয়া রেনাটা" অপকর্মে বেপরোয়া রেনাটা. Bangladesh Pratidin (in Bengali). Retrieved 2018-01-10.
External links
[edit]- Renata Limited Official Website
- Renata's profile with contact info on Pharma Mirror Magazine
- GAIN Official Website Archived 2010-02-01 at the Wayback Machine
- Renata Limited job circular 2020
- Video on GAIN and Renata's Partnership on Solving Malnutrition in Bangladesh Archived 2011-07-26 at the Wayback Machine
- Bangladesh Associate of Pharmaceutical Industries Official Website